Brain Monitoring for Epilepsy Diseases Market Research Report - Segmented by Product Type (Conventional Devices, Wearable Devices); Technology (Accelerometry, Deep Brain Stimulation, Responsive Neurostimulation, Vagus Nerve Stimulation); End User (Ambulatory Surgical Centers & Clinics, Diagnostic Centers, Homecare Settings, Hospitals, Neurology Centers, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-14983
Format:
Region: Global
Chapter 1. Brain Monitoring for Epilepsy Diseases Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Brain Monitoring for Epilepsy Diseases Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. Brain Monitoring for Epilepsy Diseases Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Brain Monitoring for Epilepsy Diseases Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Brain Monitoring for Epilepsy Diseases Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Brain Monitoring for Epilepsy Diseases Market - By Product Type
6.1 Conventional Devices
6.2 Wearable Devices
Chapter 7. Brain Monitoring for Epilepsy Diseases Market - By Technology
7.1 Accelerometry
7.2 Deep Brain Stimulation
7.3 Responsive Neurostimulation
7.4 Vagus Nerve Stimulation
Chapter 8. Brain Monitoring for Epilepsy Diseases Market - By End User
8.1 Ambulatory Surgical Centers & Clinics
8.2 Diagnostic Centers
8.3 Homecare Settings
8.4 Hospitals
8.5 Neurology Centers
8.6 Others
Chapter 9. Brain Monitoring for Epilepsy Diseases Market - By Region
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
Chapter 10. Brain Monitoring for Epilepsy Diseases Market - Key Players
10.1 Magna International Inc.
10.2 Foxconn Technology Group
10.3 BYD Company Ltd.
10.4 Daimler AG
10.5 Valmet Automotive Inc.
10.6 BMW AG
10.7 Rivian Automotive LLC
10.8 Faraday Future Inc.
10.9 Fisker Inc.
10.10 Stellantis N.V.
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Global Brain Monitoring for Epilepsy Diseases Market was estimated to be worth USD 497.5 Million in 2022 and is projected to reach a value of USD 712.9 Million by 2030, growing at a CAGR of 4.6% during the forecast period 2023-2030.
The Global Brain Monitoring for Epilepsy Diseases Market Drivers are the Rising Incidence of Epilepsy and the Increasing Government Investments in the Treatment of Epilepsy.
Based on the Technology, the Global Brain Monitoring for Epilepsy Diseases Market is segmented into Accelerometry, Deep Brain Stimulation, Responsive Neurostimulation, and Vagus Nerve Stimulation.
The United States is the most dominating country in the region of North America for the Global Brain Monitoring for Epilepsy Diseases Market.
Medtronic plc, Cadwell Industries, Inc., and Nihon Kohden Corporation are the leading players in the Global Brain Monitoring for Epilepsy Diseases Market.
